General Information of the Compound
| Compound ID |
CP0859674
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(R)-N-Benzyl-2-(4-(3-cyano-5-fluorobenzoyl)piperazin-1-yl)-2-phenylacetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H25FN4O2
|
||||||||||||||||||
| Molecular Weight |
456.521
|
||||||||||||||||||
| Canonical SMILES |
N#Cc1cc(F)cc(C(=O)N2CCN([C@@H](C(=O)NCc3ccccc3)c3ccccc3)CC2)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H25FN4O2/c28-24-16-21(18-29)15-23(17-24)27(34)32-13-11-31(12-14-32)25(22-9-5-2-6-10-22)26(33)30-19-20-7-3-1-4-8-20/h1-10,15-17,25H,11-14,19H2,(H,30,33)/t25-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
IAQGUWPCVZBXRG-RUZDIDTESA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01105, Sodium channel protein type 5 subunit alpha
Protein ID: PT01000, Sodium channel protein type 9 subunit alpha